Tesamorelin (INN) 2mg/vial

Email: info@bulkrawspharma.com
Telegram/Wickr: edisond

Storage: 2~8°C

Assay: USP 98%+ by HPLC
Minimum Order: 1g or one vial.

CONTACT US 

Free worldwide shipping on all orders over $250

  • Payment: Bitcoin, T/T Bank wire, western union.
  • Fast delivery, Stealth shipping,safe packing .
  • GMP standard factory guaranteed.
Guaranteed Safe Checkout

Table of Contents

Tesamorelin Peptide Powder Briefing

Tesamorelin is a stabilized synthetic peptide analogue of the hypothalamic peptide, Growth Hormone Releasing Hormone (GHRH) indicated for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Lipodystrophy is a metabolic condition characterized by insulin resistance, fat redistribution, and hyperlipidemia associated with antiretroviral therapy for HIV infection.

Tesamorelin (INN) (trade name Egrifta) is a synthetic form of growth-hormone-releasing hormone (GHRH) which is used in the treatment of HIV-associated lipodystrophy. It is produced and developed by Theratechnologies, Inc. of Canada.
Tesamorelin is a synthetic peptide consisting of all 44 amino acids of human GHRH with the addition of a trans-3-hexenoic acid group.
Tesamorelin is used for Reducing excess stomach fat in certain HIV-infected patients.
Tesamorelin is a human growth hormone-releasing factor (GRF) analog. It works by stimulating the pituitary gland to release growth hormone (GH). This causes the breakdown of excess stomach fat.

Product name:TesamorelinPurity:98% min
CAS NO:218949-48-5Solubility:Soluble in DMSO
Molecular Formula:C221H366N72O67SPackage:Package according to customer requirements
Molecular Weight:5135.78Storage:-20℃

Tesamorelin Single Impurity (HPLC): 0.5%max
Tesamorelin Amino Acid Composition: ± 10% of theoretical
Tesamorelin Peptide Content(N%): ≥ 80.0%
Tesamorelin Water Content(Karl Fischer): ≤ 8.0%
Tesamorelin Acetate Content(HPIC): ≤ 10.0%
Tesamorelin Specific Rotation (20/D): -55.0~-65.0° (c=1 1%HAc)
Tesamorelin MS(ESI): Consistent
Tesamorelin Mass Balance: 95.0~105.0%

Tesamorelin Peptide Powder Application

Tesamorelin has been shown to reduce lipodystrophy in HIV-infected individuals. Lipodystrophy is a condition that causes changes in placement of body fat, including wasting and fat accumulation, and changes in metabolism. Similar to Tesamorelin is Sermorelin, which may be taken with GHRP-6 is clinical trials, that also promotes HGH production and possible fat loss.Individuals with lipodystrophy may develop excess fat most notably around the liver, stomach, and other abdominal organs (visceral body fat).

How to use Tesamorelin Peptide Powder ?

First off, you’ll need a prescription in order to access this peptide. It may be difficult to get a prescription if you’re not HIV-positive, at least at the moment. In the future, this prescription-grade peptide may become much simpler to access. At present, many peptides are available without prescriptions, although some of them still require a doctor’s prescription.This peptide is an injectable. It comes in a dried format and it’s meant to be reconstituted with sterile water before being injected. Full instructions should be included with each vial of Tesamorelin.To reconstitute this lyophilized powder, add 2.1 milliliters of diluent and then combine both
ingredients by carefully rolling the tube within your hands for half a minute. Don’t shake the mixture before you use it. Being too aggressive while mixing it may damage its efficacy and this is why it
must be handled gently at all times.To store unused portions of this peptide, keep it in a fridge which features a temperature between 2-8 Celcius. Don’t store it past the expiration date. Also, keep it away from light and don’t let it freeze. Also, store diluents according to package directions.

Reviews

There are no reviews yet.

Be the first to review “Tesamorelin (INN) 2mg/vial”

Your email address will not be published. Required fields are marked *